Pierre Dubus

6PUBLICATIONS
40CO-AUTHORS
Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOrganic green chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2025
Cytolethal Distending Toxin-Increased DNA Damage and Ploidy Involve the YAP/TAZ-TEAD Signaling Pathway.

Ruxue Jia, Lamia Azzi-Martin, Mariana Saraiva

|Dec 04, 2024
Recurrent primary cutaneous marginal zone lymphoma: a comparative study of initial tumours, recurrences, and outcomes in 61 patients.

Fanny Beltzung, Marie Beylot-Barry, Maxime Battistella

|Feb 28, 2024
Cytolethal Distending Toxin Modulates Cell Differentiation and Elicits Epithelial to Mesenchymal Transition.

Lamia Azzi-Martin, Valentin Touffait-Calvez, Maude Everaert

|Dec 23, 2023
The "StemDif Sensor Test": A Straightforward, Non-Invasive Assay to Characterize the Secreted Stemness and/or Differentiation Activities of Tumor-Derived Cancer Cell Lines.

Aya Abou Hammoud, Julie Giraud, Xavier Gauthereau

|May 28, 2022
Loxl2 and Loxl3 Paralogues Play Redundant Roles during Mouse Development.

Patricia G Santamaría, Pierre Dubus, José Bustos-Tauler

|Jun 19, 2021
E2A Modulates Stemness, Metastasis, and Therapeutic Resistance of Breast Cancer.

Celia López-Menéndez, Alberto Vázquez-Naharro, Vanesa Santos

Pageof 1

Frequent Collaborators

3 joint publications

Christine Varon

2 joint publications

Armelle Ménard

2 joint publications

Lamia Azzi-Martin

2 joint publications

Elodie Sifré